Related Experiment Videos
AIDS dementia complex: evaluation with proton MR spectroscopic imaging
P B Barker1, R R Lee, J C McArthur
1Department of Radiology, Johns Hopkins University Schools of Medicine and Public Health, Baltimore, Md.
Radiology
|April 1, 1995
Summary
Proton MR spectroscopic imaging reveals significant metabolic changes in acquired immunodeficiency syndrome dementia complex (ADC). This advanced technique is more sensitive than conventional MR imaging for detecting central nervous system involvement in ADC patients.
Area of Science:
- Neuroimaging
- Biochemistry
- Infectious Diseases
Background:
- Acquired immunodeficiency syndrome dementia complex (ADC) is a neurological complication of HIV infection.
- Conventional MR imaging may not fully capture the extent of metabolic changes in ADC.
- Understanding these changes is crucial for diagnosis and management.
Purpose of the Study:
- To investigate cerebral metabolic alterations in ADC using proton magnetic resonance (MR) spectroscopic imaging.
- To compare the sensitivity of MR spectroscopic imaging with conventional MR imaging in detecting ADC-related central nervous system involvement.
Main Methods:
- Seven male patients diagnosed with ADC and seven age-matched HIV-negative volunteers participated.
- Both groups underwent conventional MR imaging and proton MR spectroscopic imaging.
- Spectroscopic data were analyzed for metabolic profiles in white-matter regions and cerebrospinal fluid.
Main Results:
- ADC patients exhibited reduced N-acetyl aspartate and elevated choline levels in white matter.
- Lactate was detected in the cerebrospinal fluid of five ADC patients.
- Metabolic abnormalities were more pronounced in patients with moderate dementia compared to those with mild neurocognitive changes.
Conclusions:
- Proton MR spectroscopic imaging effectively demonstrates widespread metabolic changes in ADC.
- MR spectroscopic imaging is more sensitive than conventional MR imaging for detecting CNS involvement in ADC.
- This technique offers a valuable tool for assessing the neurological impact of HIV infection.